NCT06313255View on ClinicalTrials.gov

A Retrospective Observational Study on the Effects of Probiotics on HBsAg Clearance

RecruitingOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

May 9, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Chronic Hepatitis B
Interventions
DRUG

PegIFNα2b

The patients receive PegIFNα2b therapy

DRUG

PegIFNα2b+probiotics

The patients receive both PegIFNα2b and probiotics therapy

DRUG

Nucleoside analog

The patients receive nucleoside analog therapy

DRUG

Nucleoside analog+probiotics

The patients receive both nucleoside analog and probiotics therapy

Trial Locations (1)

250012

RECRUITING

Qilu Hospital of Shandong University, Jinan

All Listed Sponsors
lead

Qilu Hospital of Shandong University

OTHER